Having trouble accessing articles? Reset your cache.

Somatoprim: Phase IIa data

Top-line data from an open-label, Ukrainian Phase IIa trial in about 20 treatment-naïve patients with acromegaly showed that single ascending-doses

Read the full 201 word article

User Sign In

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE